PF-06651600
Showing 1 - 25 of 1,087
Healthy Volunteers, Adult, Pharmacokinetics Trial in Brussels (Ritlecitinib)
Not yet recruiting
- Healthy Volunteers
- +2 more
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
May 1, 2023
CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)
Recruiting
- CTCL
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 18, 2023
Healthy Trial in New Haven (Ritlecitinib 50 mg, Ritlecitinib 200 mg)
Completed
- Healthy
- Ritlecitinib 50 mg
- Ritlecitinib 200 mg
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Feb 4, 2022
Healthy Volunteers Trial in New Haven (Ritlecitinib, Tolbutamide)
Completed
- Healthy Volunteers
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 18, 2022
Cicatricial Alopecia Trial in New York (PF-06651600)
Not yet recruiting
- Cicatricial Alopecia
- PF-06651600
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 19, 2022
Healthy Participants Trial in Hollywood, Saint Paul (PF-06651600)
Completed
- Healthy Participants
- PF-06651600
-
Hollywood, Florida
- +1 more
Aug 2, 2021
Hepatic Impairment, Healthy Participants Trial in Miami, Orlando (PF-06651600 30 mg)
Completed
- Hepatic Impairment
- Healthy Participants
- PF-06651600 30 mg
-
Miami, Florida
- +1 more
Apr 7, 2021
Healthy Participants Trial in Beijing (PF-06651600)
Completed
- Healthy Participants
- PF-06651600
-
Beijing, Beijing, China
- +1 more
Feb 16, 2021
Healthy Participants Trial in New Haven (Caffeine, Ritlecitinib)
Completed
- Healthy Participants
- Caffeine
- Ritlecitinib
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Mar 17, 2021
Active Non-segmental Vitiligo Trial in Worldwide (PF-06651600, , PF06700841)
Completed
- Active Non-segmental Vitiligo
- PF-06651600
- +3 more
-
Huntington Beach, California
- +91 more
Mar 1, 2022
Healthy Participants Trial in New Haven (ritlecitinib)
Completed
- Healthy Participants
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 20, 2022
Healthy Volunteers Trial in Brussels (PF-06651600, Rifampin)
Completed
- Healthy Volunteers
- PF-06651600
- Rifampin
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Sep 14, 2020
Healthy Volunteers Trial in New Haven (Sumatriptan, PF-06651600)
Completed
- Healthy Volunteers
- Sumatriptan
- PF-06651600
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Sep 1, 2020
Healthy Trial in New Haven (PF-06650833 alone, PF-06651600 alone, PF-06650833 together with PF-06651600)
Completed
- Healthy
- PF-06650833 alone
- +2 more
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
May 18, 2020
Crohn's Disease Trial in Worldwide (PF-06651600 Placebo, PF-06651600, Placebo PF-06700841)
Active, not recruiting
- Crohn's Disease
- PF-06651600 Placebo
- +3 more
-
Dothan, Alabama
- +187 more
Aug 17, 2022
Alopecia Areata Trial in Worldwide (PF-06651600 Induction Dose, PF-06651600 Maintenance Dose #1, PF-06651600 Maintenance Dose
Completed
- Alopecia Areata
- PF-06651600 Induction Dose
- +4 more
-
Birmingham, Alabama
- +154 more
Feb 1, 2022
Healthy Volunteers Trial in Brussels (PF-06651600, Rosuvastatin)
Completed
- Healthy Volunteers
- PF-06651600
- Rosuvastatin
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Feb 4, 2020
Alopecia Areata Trial in Worldwide (PF-06651600, Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine,
Active, not recruiting
- Alopecia Areata
- PF-06651600
- +2 more
-
Birmingham, Alabama
- +148 more
Aug 17, 2022
Healthy Volunteers Trial in Brussels (PF-06651600)
Completed
- Healthy Volunteers
- PF-06651600
-
Brussels, Be-bru, BelgiumBrussels Clinical Research Unit
Oct 30, 2019
Healthy Trial in Coral Gables, Miami (PF-06651600, Ethinyl estradiol (EE) and levonorgestrel(LN))
Completed
- Healthy
- PF-06651600
- Ethinyl estradiol (EE) and levonorgestrel(LN)
-
Coral Gables, Florida
- +1 more
Nov 13, 2019
Healthy Participants Trial in Brussels (PF-06651600 10 mg tablets, Itraconazole Solution 200 mg)
Completed
- Healthy Participants
- PF-06651600 10 mg tablets
- Itraconazole Solution 200 mg
-
Brussels, Be-bru, BelgiumPfizer Clinical Research Unit
Jun 27, 2019
Healthy Participants Trial in Brussels (PF-06651600 20 mg, Bitrex solution)
Completed
- Healthy Participants
- PF-06651600 20 mg
- Bitrex solution
-
Brussels, Be-bru, BelgiumPfizer Clinical Research Unit
Jun 4, 2019